ID   SCSe001-A
AC   CVCL_B863
SY   MEL-1; Mel-1; Mel 1; Mel1; MEL1
DR   BioSamples; SAMEA7783168
DR   GEO; GSM1053949
DR   GEO; GSM1053950
DR   GEO; GSM1053951
DR   hPSCreg; SCSe001-A
DR   Millipore; SCC020
DR   NIHhESC; NIHhESC-11-0139
DR   SKIP; SKIP001931
DR   Wikidata; Q54952661
RX   PubMed=17572666;
RX   PubMed=23225669;
RX   PubMed=28445466;
WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/mel-1.aspx
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0139.
CC   Registration: Swiss research registry; BAG-hES-IMP-0003.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-001, Steering comm. appl. SCSC04-30.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Millipore; SCC020; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
RX   PubMed=17572666; DOI=10.1038/nbt1318;
RA   Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W.,
RA   Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B.,
RA   Brooking J., Chen K.G., Choo A.B.-H., Churchill G.A., Corbel M.,
RA   Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A.,
RA   Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S.,
RA   Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P.,
RA   Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K.,
RA   King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D.,
RA   Mayshar Y., McKay R.D.G., Michalska A.E., Mikkola M., Mileikovsky M.,
RA   Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N.,
RA   O'Brien C.M., Oh S.K.-W., Olsson C., Otonkoski T., Park K.-Y.,
RA   Passier R., Patel H., Patel M.J., Pedersen R., Pera M.F.,
RA   Piekarczyk M.S., Reijo Pera R.A., Reubinoff B.E., Robins A.J.,
RA   Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H.,
RA   Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T.T.,
RA   Tuuri T., van den Brink S., Vintersten K., Vuoristo S.,
RA   Ward-van Oostwaard D., Weaver T.A., Young L.A., Zhang W.-D.;
RG   International Stem Cell Initiative;
RT   "Characterization of human embryonic stem cell lines by the
RT   International Stem Cell Initiative.";
RL   Nat. Biotechnol. 25:803-816(2007).
//
RX   PubMed=23225669; DOI=10.1002/stem.1297;
RA   Briggs J.A., Sun J., Shepherd J., Ovchinnikov D.A., Chung T.-L.,
RA   Nayler S.P., Kao L.-P., Morrow C.A., Thakar N.Y., Soo S.-Y., Peura T.T.,
RA   Grimmond S.M., Wolvetang E.J.;
RT   "Integration-free induced pluripotent stem cells model genetic and
RT   neural developmental features of Down syndrome etiology.";
RL   Stem Cells 31:467-478(2013).
//
RX   PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative p53 mutations.";
RL   Nature 545:229-233(2017).
//